nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—ABCG2—Dactinomycin—testicular cancer	0.116	0.169	CbGbCtD
Rabeprazole—ABCG2—Carboplatin—testicular cancer	0.0779	0.114	CbGbCtD
Rabeprazole—ABCG2—Cisplatin—testicular cancer	0.0666	0.097	CbGbCtD
Rabeprazole—ABCG2—Etoposide—testicular cancer	0.0654	0.0953	CbGbCtD
Rabeprazole—CYP2C19—Ifosfamide—testicular cancer	0.0612	0.0891	CbGbCtD
Rabeprazole—CYP2C9—Ifosfamide—testicular cancer	0.0508	0.0741	CbGbCtD
Rabeprazole—ABCG2—Doxorubicin—testicular cancer	0.0446	0.065	CbGbCtD
Rabeprazole—ABCG2—Methotrexate—testicular cancer	0.0432	0.063	CbGbCtD
Rabeprazole—CYP3A4—Ifosfamide—testicular cancer	0.0296	0.0431	CbGbCtD
Rabeprazole—CYP1A2—Etoposide—testicular cancer	0.027	0.0393	CbGbCtD
Rabeprazole—CYP2C9—Cisplatin—testicular cancer	0.0247	0.036	CbGbCtD
Rabeprazole—CYP2D6—Vinblastine—testicular cancer	0.0247	0.0359	CbGbCtD
Rabeprazole—CYP3A4—Vinblastine—testicular cancer	0.0157	0.0229	CbGbCtD
Rabeprazole—CYP2D6—Doxorubicin—testicular cancer	0.0152	0.0221	CbGbCtD
Rabeprazole—CYP3A4—Etoposide—testicular cancer	0.0141	0.0206	CbGbCtD
Rabeprazole—CYP3A4—Doxorubicin—testicular cancer	0.00964	0.014	CbGbCtD
Rabeprazole—Urinary tract disorder—Methotrexate—testicular cancer	0.000159	0.000506	CcSEcCtD
Rabeprazole—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000159	0.000506	CcSEcCtD
Rabeprazole—Weight increased—Doxorubicin—testicular cancer	0.000158	0.000505	CcSEcCtD
Rabeprazole—Epistaxis—Epirubicin—testicular cancer	0.000158	0.000504	CcSEcCtD
Rabeprazole—Urethral disorder—Methotrexate—testicular cancer	0.000158	0.000503	CcSEcCtD
Rabeprazole—Weight decreased—Doxorubicin—testicular cancer	0.000158	0.000502	CcSEcCtD
Rabeprazole—Sinusitis—Epirubicin—testicular cancer	0.000157	0.000501	CcSEcCtD
Rabeprazole—Feeling abnormal—Etoposide—testicular cancer	0.000157	0.000501	CcSEcCtD
Rabeprazole—Hyperglycaemia—Doxorubicin—testicular cancer	0.000157	0.0005	CcSEcCtD
Rabeprazole—Nausea—Dactinomycin—testicular cancer	0.000157	0.000499	CcSEcCtD
Rabeprazole—Agranulocytosis—Epirubicin—testicular cancer	0.000157	0.000499	CcSEcCtD
Rabeprazole—Pneumonia—Doxorubicin—testicular cancer	0.000156	0.000497	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Etoposide—testicular cancer	0.000156	0.000497	CcSEcCtD
Rabeprazole—Visual impairment—Methotrexate—testicular cancer	0.000155	0.000494	CcSEcCtD
Rabeprazole—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000154	0.00049	CcSEcCtD
Rabeprazole—Vomiting—Ifosfamide—testicular cancer	0.000154	0.00049	CcSEcCtD
Rabeprazole—Hypersensitivity—Cisplatin—testicular cancer	0.000154	0.000489	CcSEcCtD
Rabeprazole—Bradycardia—Epirubicin—testicular cancer	0.000153	0.000488	CcSEcCtD
Rabeprazole—Rash—Ifosfamide—testicular cancer	0.000152	0.000486	CcSEcCtD
Rabeprazole—Dermatitis—Ifosfamide—testicular cancer	0.000152	0.000485	CcSEcCtD
Rabeprazole—Erythema multiforme—Methotrexate—testicular cancer	0.000152	0.000485	CcSEcCtD
Rabeprazole—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000152	0.000485	CcSEcCtD
Rabeprazole—Urticaria—Etoposide—testicular cancer	0.000152	0.000483	CcSEcCtD
Rabeprazole—Stomatitis—Doxorubicin—testicular cancer	0.000151	0.000482	CcSEcCtD
Rabeprazole—Jaundice—Doxorubicin—testicular cancer	0.000151	0.000482	CcSEcCtD
Rabeprazole—Rhinitis—Epirubicin—testicular cancer	0.000151	0.000481	CcSEcCtD
Rabeprazole—Abdominal pain—Etoposide—testicular cancer	0.000151	0.000481	CcSEcCtD
Rabeprazole—Body temperature increased—Etoposide—testicular cancer	0.000151	0.000481	CcSEcCtD
Rabeprazole—Conjunctivitis—Doxorubicin—testicular cancer	0.000151	0.000481	CcSEcCtD
Rabeprazole—Urinary tract infection—Doxorubicin—testicular cancer	0.000151	0.000481	CcSEcCtD
Rabeprazole—Hepatitis—Epirubicin—testicular cancer	0.000151	0.00048	CcSEcCtD
Rabeprazole—Eye disorder—Methotrexate—testicular cancer	0.00015	0.000479	CcSEcCtD
Rabeprazole—Tinnitus—Methotrexate—testicular cancer	0.00015	0.000478	CcSEcCtD
Rabeprazole—Asthenia—Cisplatin—testicular cancer	0.000149	0.000476	CcSEcCtD
Rabeprazole—Pharyngitis—Epirubicin—testicular cancer	0.000149	0.000476	CcSEcCtD
Rabeprazole—Sweating—Doxorubicin—testicular cancer	0.000149	0.000474	CcSEcCtD
Rabeprazole—Urinary tract disorder—Epirubicin—testicular cancer	0.000149	0.000474	CcSEcCtD
Rabeprazole—Oedema peripheral—Epirubicin—testicular cancer	0.000148	0.000473	CcSEcCtD
Rabeprazole—Haematuria—Doxorubicin—testicular cancer	0.000148	0.000472	CcSEcCtD
Rabeprazole—Urethral disorder—Epirubicin—testicular cancer	0.000148	0.00047	CcSEcCtD
Rabeprazole—Epistaxis—Doxorubicin—testicular cancer	0.000146	0.000466	CcSEcCtD
Rabeprazole—Angiopathy—Methotrexate—testicular cancer	0.000146	0.000465	CcSEcCtD
Rabeprazole—Sinusitis—Doxorubicin—testicular cancer	0.000146	0.000464	CcSEcCtD
Rabeprazole—Visual impairment—Epirubicin—testicular cancer	0.000145	0.000462	CcSEcCtD
Rabeprazole—Agranulocytosis—Doxorubicin—testicular cancer	0.000145	0.000462	CcSEcCtD
Rabeprazole—Chills—Methotrexate—testicular cancer	0.000144	0.00046	CcSEcCtD
Rabeprazole—Nausea—Ifosfamide—testicular cancer	0.000144	0.000457	CcSEcCtD
Rabeprazole—Diarrhoea—Cisplatin—testicular cancer	0.000143	0.000454	CcSEcCtD
Rabeprazole—Erythema multiforme—Epirubicin—testicular cancer	0.000142	0.000454	CcSEcCtD
Rabeprazole—Alopecia—Methotrexate—testicular cancer	0.000142	0.000453	CcSEcCtD
Rabeprazole—Bradycardia—Doxorubicin—testicular cancer	0.000142	0.000452	CcSEcCtD
Rabeprazole—Eye disorder—Epirubicin—testicular cancer	0.000141	0.000448	CcSEcCtD
Rabeprazole—Hypersensitivity—Etoposide—testicular cancer	0.000141	0.000448	CcSEcCtD
Rabeprazole—Tinnitus—Epirubicin—testicular cancer	0.00014	0.000447	CcSEcCtD
Rabeprazole—Erythema—Methotrexate—testicular cancer	0.00014	0.000446	CcSEcCtD
Rabeprazole—Malnutrition—Methotrexate—testicular cancer	0.00014	0.000446	CcSEcCtD
Rabeprazole—Rhinitis—Doxorubicin—testicular cancer	0.00014	0.000445	CcSEcCtD
Rabeprazole—Hepatitis—Doxorubicin—testicular cancer	0.000139	0.000444	CcSEcCtD
Rabeprazole—Pharyngitis—Doxorubicin—testicular cancer	0.000138	0.000441	CcSEcCtD
Rabeprazole—Urinary tract disorder—Doxorubicin—testicular cancer	0.000138	0.000438	CcSEcCtD
Rabeprazole—Oedema peripheral—Doxorubicin—testicular cancer	0.000137	0.000437	CcSEcCtD
Rabeprazole—Dysgeusia—Methotrexate—testicular cancer	0.000137	0.000437	CcSEcCtD
Rabeprazole—Asthenia—Etoposide—testicular cancer	0.000137	0.000436	CcSEcCtD
Rabeprazole—Angiopathy—Epirubicin—testicular cancer	0.000137	0.000435	CcSEcCtD
Rabeprazole—Urethral disorder—Doxorubicin—testicular cancer	0.000137	0.000435	CcSEcCtD
Rabeprazole—Back pain—Methotrexate—testicular cancer	0.000136	0.000432	CcSEcCtD
Rabeprazole—Chills—Epirubicin—testicular cancer	0.000135	0.000431	CcSEcCtD
Rabeprazole—Pruritus—Etoposide—testicular cancer	0.000135	0.00043	CcSEcCtD
Rabeprazole—Arrhythmia—Epirubicin—testicular cancer	0.000135	0.000429	CcSEcCtD
Rabeprazole—Visual impairment—Doxorubicin—testicular cancer	0.000134	0.000428	CcSEcCtD
Rabeprazole—Alopecia—Epirubicin—testicular cancer	0.000133	0.000424	CcSEcCtD
Rabeprazole—Vomiting—Cisplatin—testicular cancer	0.000132	0.000422	CcSEcCtD
Rabeprazole—Vision blurred—Methotrexate—testicular cancer	0.000132	0.000421	CcSEcCtD
Rabeprazole—Erythema multiforme—Doxorubicin—testicular cancer	0.000132	0.00042	CcSEcCtD
Rabeprazole—Rash—Cisplatin—testicular cancer	0.000131	0.000419	CcSEcCtD
Rabeprazole—Dermatitis—Cisplatin—testicular cancer	0.000131	0.000418	CcSEcCtD
Rabeprazole—Erythema—Epirubicin—testicular cancer	0.000131	0.000418	CcSEcCtD
Rabeprazole—Malnutrition—Epirubicin—testicular cancer	0.000131	0.000418	CcSEcCtD
Rabeprazole—Diarrhoea—Etoposide—testicular cancer	0.000131	0.000416	CcSEcCtD
Rabeprazole—Eye disorder—Doxorubicin—testicular cancer	0.00013	0.000415	CcSEcCtD
Rabeprazole—Ill-defined disorder—Methotrexate—testicular cancer	0.00013	0.000414	CcSEcCtD
Rabeprazole—Tinnitus—Doxorubicin—testicular cancer	0.00013	0.000414	CcSEcCtD
Rabeprazole—Anaemia—Methotrexate—testicular cancer	0.000129	0.000413	CcSEcCtD
Rabeprazole—Flatulence—Epirubicin—testicular cancer	0.000129	0.000412	CcSEcCtD
Rabeprazole—Tension—Epirubicin—testicular cancer	0.000129	0.00041	CcSEcCtD
Rabeprazole—Dysgeusia—Epirubicin—testicular cancer	0.000128	0.000409	CcSEcCtD
Rabeprazole—Nervousness—Epirubicin—testicular cancer	0.000127	0.000406	CcSEcCtD
Rabeprazole—Back pain—Epirubicin—testicular cancer	0.000127	0.000404	CcSEcCtD
Rabeprazole—Angiopathy—Doxorubicin—testicular cancer	0.000126	0.000403	CcSEcCtD
Rabeprazole—Malaise—Methotrexate—testicular cancer	0.000126	0.000403	CcSEcCtD
Rabeprazole—Dizziness—Etoposide—testicular cancer	0.000126	0.000402	CcSEcCtD
Rabeprazole—Muscle spasms—Epirubicin—testicular cancer	0.000126	0.000402	CcSEcCtD
Rabeprazole—Vertigo—Methotrexate—testicular cancer	0.000126	0.000401	CcSEcCtD
Rabeprazole—Leukopenia—Methotrexate—testicular cancer	0.000125	0.0004	CcSEcCtD
Rabeprazole—Chills—Doxorubicin—testicular cancer	0.000125	0.000398	CcSEcCtD
Rabeprazole—Arrhythmia—Doxorubicin—testicular cancer	0.000124	0.000397	CcSEcCtD
Rabeprazole—Nausea—Cisplatin—testicular cancer	0.000124	0.000394	CcSEcCtD
Rabeprazole—Vision blurred—Epirubicin—testicular cancer	0.000124	0.000394	CcSEcCtD
Rabeprazole—Alopecia—Doxorubicin—testicular cancer	0.000123	0.000392	CcSEcCtD
Rabeprazole—Cough—Methotrexate—testicular cancer	0.000122	0.000389	CcSEcCtD
Rabeprazole—Ill-defined disorder—Epirubicin—testicular cancer	0.000122	0.000388	CcSEcCtD
Rabeprazole—Convulsion—Methotrexate—testicular cancer	0.000121	0.000387	CcSEcCtD
Rabeprazole—Vomiting—Etoposide—testicular cancer	0.000121	0.000387	CcSEcCtD
Rabeprazole—Erythema—Doxorubicin—testicular cancer	0.000121	0.000386	CcSEcCtD
Rabeprazole—Malnutrition—Doxorubicin—testicular cancer	0.000121	0.000386	CcSEcCtD
Rabeprazole—Anaemia—Epirubicin—testicular cancer	0.000121	0.000386	CcSEcCtD
Rabeprazole—Agitation—Epirubicin—testicular cancer	0.00012	0.000384	CcSEcCtD
Rabeprazole—Rash—Etoposide—testicular cancer	0.00012	0.000383	CcSEcCtD
Rabeprazole—Dermatitis—Etoposide—testicular cancer	0.00012	0.000383	CcSEcCtD
Rabeprazole—Headache—Etoposide—testicular cancer	0.00012	0.000381	CcSEcCtD
Rabeprazole—Flatulence—Doxorubicin—testicular cancer	0.00012	0.000381	CcSEcCtD
Rabeprazole—Arthralgia—Methotrexate—testicular cancer	0.000119	0.00038	CcSEcCtD
Rabeprazole—Chest pain—Methotrexate—testicular cancer	0.000119	0.00038	CcSEcCtD
Rabeprazole—Myalgia—Methotrexate—testicular cancer	0.000119	0.00038	CcSEcCtD
Rabeprazole—Tension—Doxorubicin—testicular cancer	0.000119	0.000379	CcSEcCtD
Rabeprazole—Dysgeusia—Doxorubicin—testicular cancer	0.000119	0.000378	CcSEcCtD
Rabeprazole—Malaise—Epirubicin—testicular cancer	0.000118	0.000377	CcSEcCtD
Rabeprazole—Discomfort—Methotrexate—testicular cancer	0.000118	0.000375	CcSEcCtD
Rabeprazole—Nervousness—Doxorubicin—testicular cancer	0.000118	0.000375	CcSEcCtD
Rabeprazole—Vertigo—Epirubicin—testicular cancer	0.000118	0.000375	CcSEcCtD
Rabeprazole—Syncope—Epirubicin—testicular cancer	0.000118	0.000375	CcSEcCtD
Rabeprazole—Leukopenia—Epirubicin—testicular cancer	0.000117	0.000374	CcSEcCtD
Rabeprazole—Back pain—Doxorubicin—testicular cancer	0.000117	0.000374	CcSEcCtD
Rabeprazole—Muscle spasms—Doxorubicin—testicular cancer	0.000117	0.000372	CcSEcCtD
Rabeprazole—Palpitations—Epirubicin—testicular cancer	0.000116	0.000369	CcSEcCtD
Rabeprazole—Confusional state—Methotrexate—testicular cancer	0.000115	0.000367	CcSEcCtD
Rabeprazole—Loss of consciousness—Epirubicin—testicular cancer	0.000115	0.000367	CcSEcCtD
Rabeprazole—Cough—Epirubicin—testicular cancer	0.000114	0.000365	CcSEcCtD
Rabeprazole—Anaphylactic shock—Methotrexate—testicular cancer	0.000114	0.000364	CcSEcCtD
Rabeprazole—Vision blurred—Doxorubicin—testicular cancer	0.000114	0.000364	CcSEcCtD
Rabeprazole—Convulsion—Epirubicin—testicular cancer	0.000114	0.000362	CcSEcCtD
Rabeprazole—Nausea—Etoposide—testicular cancer	0.000113	0.000361	CcSEcCtD
Rabeprazole—Hypertension—Epirubicin—testicular cancer	0.000113	0.000361	CcSEcCtD
Rabeprazole—Ill-defined disorder—Doxorubicin—testicular cancer	0.000113	0.000359	CcSEcCtD
Rabeprazole—Anaemia—Doxorubicin—testicular cancer	0.000112	0.000357	CcSEcCtD
Rabeprazole—Thrombocytopenia—Methotrexate—testicular cancer	0.000112	0.000357	CcSEcCtD
Rabeprazole—Myalgia—Epirubicin—testicular cancer	0.000112	0.000356	CcSEcCtD
Rabeprazole—Chest pain—Epirubicin—testicular cancer	0.000112	0.000356	CcSEcCtD
Rabeprazole—Arthralgia—Epirubicin—testicular cancer	0.000112	0.000356	CcSEcCtD
Rabeprazole—Agitation—Doxorubicin—testicular cancer	0.000111	0.000355	CcSEcCtD
Rabeprazole—Anxiety—Epirubicin—testicular cancer	0.000111	0.000354	CcSEcCtD
Rabeprazole—Hyperhidrosis—Methotrexate—testicular cancer	0.000111	0.000352	CcSEcCtD
Rabeprazole—Discomfort—Epirubicin—testicular cancer	0.00011	0.000351	CcSEcCtD
Rabeprazole—Malaise—Doxorubicin—testicular cancer	0.000109	0.000349	CcSEcCtD
Rabeprazole—Dry mouth—Epirubicin—testicular cancer	0.000109	0.000348	CcSEcCtD
Rabeprazole—Vertigo—Doxorubicin—testicular cancer	0.000109	0.000347	CcSEcCtD
Rabeprazole—Anorexia—Methotrexate—testicular cancer	0.000109	0.000347	CcSEcCtD
Rabeprazole—Syncope—Doxorubicin—testicular cancer	0.000109	0.000347	CcSEcCtD
Rabeprazole—Leukopenia—Doxorubicin—testicular cancer	0.000109	0.000346	CcSEcCtD
Rabeprazole—Confusional state—Epirubicin—testicular cancer	0.000108	0.000344	CcSEcCtD
Rabeprazole—Palpitations—Doxorubicin—testicular cancer	0.000107	0.000342	CcSEcCtD
Rabeprazole—Oedema—Epirubicin—testicular cancer	0.000107	0.000341	CcSEcCtD
Rabeprazole—Anaphylactic shock—Epirubicin—testicular cancer	0.000107	0.000341	CcSEcCtD
Rabeprazole—Hypotension—Methotrexate—testicular cancer	0.000107	0.00034	CcSEcCtD
Rabeprazole—Loss of consciousness—Doxorubicin—testicular cancer	0.000107	0.00034	CcSEcCtD
Rabeprazole—Cough—Doxorubicin—testicular cancer	0.000106	0.000337	CcSEcCtD
Rabeprazole—Shock—Epirubicin—testicular cancer	0.000105	0.000335	CcSEcCtD
Rabeprazole—Convulsion—Doxorubicin—testicular cancer	0.000105	0.000335	CcSEcCtD
Rabeprazole—Thrombocytopenia—Epirubicin—testicular cancer	0.000105	0.000334	CcSEcCtD
Rabeprazole—Hypertension—Doxorubicin—testicular cancer	0.000105	0.000334	CcSEcCtD
Rabeprazole—Tachycardia—Epirubicin—testicular cancer	0.000104	0.000333	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000104	0.000332	CcSEcCtD
Rabeprazole—Hyperhidrosis—Epirubicin—testicular cancer	0.000103	0.00033	CcSEcCtD
Rabeprazole—Insomnia—Methotrexate—testicular cancer	0.000103	0.000329	CcSEcCtD
Rabeprazole—Chest pain—Doxorubicin—testicular cancer	0.000103	0.000329	CcSEcCtD
Rabeprazole—Myalgia—Doxorubicin—testicular cancer	0.000103	0.000329	CcSEcCtD
Rabeprazole—Arthralgia—Doxorubicin—testicular cancer	0.000103	0.000329	CcSEcCtD
Rabeprazole—Anxiety—Doxorubicin—testicular cancer	0.000103	0.000328	CcSEcCtD
Rabeprazole—Paraesthesia—Methotrexate—testicular cancer	0.000103	0.000327	CcSEcCtD
Rabeprazole—Discomfort—Doxorubicin—testicular cancer	0.000102	0.000325	CcSEcCtD
Rabeprazole—Anorexia—Epirubicin—testicular cancer	0.000102	0.000325	CcSEcCtD
Rabeprazole—Dyspnoea—Methotrexate—testicular cancer	0.000102	0.000325	CcSEcCtD
Rabeprazole—Somnolence—Methotrexate—testicular cancer	0.000102	0.000324	CcSEcCtD
Rabeprazole—Dry mouth—Doxorubicin—testicular cancer	0.000101	0.000322	CcSEcCtD
Rabeprazole—Dyspepsia—Methotrexate—testicular cancer	0.000101	0.000321	CcSEcCtD
Rabeprazole—Hypotension—Epirubicin—testicular cancer	0.0001	0.000319	CcSEcCtD
Rabeprazole—Confusional state—Doxorubicin—testicular cancer	9.98e-05	0.000318	CcSEcCtD
Rabeprazole—Decreased appetite—Methotrexate—testicular cancer	9.94e-05	0.000317	CcSEcCtD
Rabeprazole—Anaphylactic shock—Doxorubicin—testicular cancer	9.9e-05	0.000315	CcSEcCtD
Rabeprazole—Oedema—Doxorubicin—testicular cancer	9.9e-05	0.000315	CcSEcCtD
Rabeprazole—Pain—Methotrexate—testicular cancer	9.78e-05	0.000312	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Epirubicin—testicular cancer	9.75e-05	0.000311	CcSEcCtD
Rabeprazole—Shock—Doxorubicin—testicular cancer	9.74e-05	0.00031	CcSEcCtD
Rabeprazole—Thrombocytopenia—Doxorubicin—testicular cancer	9.69e-05	0.000309	CcSEcCtD
Rabeprazole—Insomnia—Epirubicin—testicular cancer	9.68e-05	0.000308	CcSEcCtD
Rabeprazole—Tachycardia—Doxorubicin—testicular cancer	9.66e-05	0.000308	CcSEcCtD
Rabeprazole—Paraesthesia—Epirubicin—testicular cancer	9.61e-05	0.000306	CcSEcCtD
Rabeprazole—Hyperhidrosis—Doxorubicin—testicular cancer	9.57e-05	0.000305	CcSEcCtD
Rabeprazole—Dyspnoea—Epirubicin—testicular cancer	9.54e-05	0.000304	CcSEcCtD
Rabeprazole—Somnolence—Epirubicin—testicular cancer	9.51e-05	0.000303	CcSEcCtD
Rabeprazole—Anorexia—Doxorubicin—testicular cancer	9.44e-05	0.000301	CcSEcCtD
Rabeprazole—Feeling abnormal—Methotrexate—testicular cancer	9.42e-05	0.0003	CcSEcCtD
Rabeprazole—Dyspepsia—Epirubicin—testicular cancer	9.42e-05	0.0003	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Methotrexate—testicular cancer	9.35e-05	0.000298	CcSEcCtD
Rabeprazole—Decreased appetite—Epirubicin—testicular cancer	9.3e-05	0.000296	CcSEcCtD
Rabeprazole—Hypotension—Doxorubicin—testicular cancer	9.25e-05	0.000295	CcSEcCtD
Rabeprazole—Constipation—Epirubicin—testicular cancer	9.15e-05	0.000292	CcSEcCtD
Rabeprazole—Pain—Epirubicin—testicular cancer	9.15e-05	0.000292	CcSEcCtD
Rabeprazole—Urticaria—Methotrexate—testicular cancer	9.08e-05	0.000289	CcSEcCtD
Rabeprazole—Abdominal pain—Methotrexate—testicular cancer	9.04e-05	0.000288	CcSEcCtD
Rabeprazole—Body temperature increased—Methotrexate—testicular cancer	9.04e-05	0.000288	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Doxorubicin—testicular cancer	9.02e-05	0.000287	CcSEcCtD
Rabeprazole—Insomnia—Doxorubicin—testicular cancer	8.95e-05	0.000285	CcSEcCtD
Rabeprazole—Paraesthesia—Doxorubicin—testicular cancer	8.89e-05	0.000283	CcSEcCtD
Rabeprazole—Dyspnoea—Doxorubicin—testicular cancer	8.83e-05	0.000281	CcSEcCtD
Rabeprazole—Feeling abnormal—Epirubicin—testicular cancer	8.82e-05	0.000281	CcSEcCtD
Rabeprazole—Somnolence—Doxorubicin—testicular cancer	8.8e-05	0.00028	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Epirubicin—testicular cancer	8.75e-05	0.000279	CcSEcCtD
Rabeprazole—Dyspepsia—Doxorubicin—testicular cancer	8.72e-05	0.000278	CcSEcCtD
Rabeprazole—Decreased appetite—Doxorubicin—testicular cancer	8.61e-05	0.000274	CcSEcCtD
Rabeprazole—Urticaria—Epirubicin—testicular cancer	8.5e-05	0.000271	CcSEcCtD
Rabeprazole—Constipation—Doxorubicin—testicular cancer	8.47e-05	0.00027	CcSEcCtD
Rabeprazole—Pain—Doxorubicin—testicular cancer	8.47e-05	0.00027	CcSEcCtD
Rabeprazole—Body temperature increased—Epirubicin—testicular cancer	8.46e-05	0.000269	CcSEcCtD
Rabeprazole—Abdominal pain—Epirubicin—testicular cancer	8.46e-05	0.000269	CcSEcCtD
Rabeprazole—Hypersensitivity—Methotrexate—testicular cancer	8.42e-05	0.000268	CcSEcCtD
Rabeprazole—Asthenia—Methotrexate—testicular cancer	8.2e-05	0.000261	CcSEcCtD
Rabeprazole—Feeling abnormal—Doxorubicin—testicular cancer	8.16e-05	0.00026	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Doxorubicin—testicular cancer	8.1e-05	0.000258	CcSEcCtD
Rabeprazole—Pruritus—Methotrexate—testicular cancer	8.09e-05	0.000258	CcSEcCtD
Rabeprazole—Hypersensitivity—Epirubicin—testicular cancer	7.88e-05	0.000251	CcSEcCtD
Rabeprazole—Urticaria—Doxorubicin—testicular cancer	7.87e-05	0.000251	CcSEcCtD
Rabeprazole—Abdominal pain—Doxorubicin—testicular cancer	7.83e-05	0.000249	CcSEcCtD
Rabeprazole—Body temperature increased—Doxorubicin—testicular cancer	7.83e-05	0.000249	CcSEcCtD
Rabeprazole—Diarrhoea—Methotrexate—testicular cancer	7.82e-05	0.000249	CcSEcCtD
Rabeprazole—Asthenia—Epirubicin—testicular cancer	7.68e-05	0.000245	CcSEcCtD
Rabeprazole—Pruritus—Epirubicin—testicular cancer	7.57e-05	0.000241	CcSEcCtD
Rabeprazole—Dizziness—Methotrexate—testicular cancer	7.56e-05	0.000241	CcSEcCtD
Rabeprazole—Diarrhoea—Epirubicin—testicular cancer	7.32e-05	0.000233	CcSEcCtD
Rabeprazole—Hypersensitivity—Doxorubicin—testicular cancer	7.29e-05	0.000232	CcSEcCtD
Rabeprazole—Vomiting—Methotrexate—testicular cancer	7.27e-05	0.000232	CcSEcCtD
Rabeprazole—Rash—Methotrexate—testicular cancer	7.21e-05	0.00023	CcSEcCtD
Rabeprazole—Dermatitis—Methotrexate—testicular cancer	7.2e-05	0.000229	CcSEcCtD
Rabeprazole—Headache—Methotrexate—testicular cancer	7.16e-05	0.000228	CcSEcCtD
Rabeprazole—Asthenia—Doxorubicin—testicular cancer	7.1e-05	0.000226	CcSEcCtD
Rabeprazole—Dizziness—Epirubicin—testicular cancer	7.08e-05	0.000225	CcSEcCtD
Rabeprazole—Pruritus—Doxorubicin—testicular cancer	7e-05	0.000223	CcSEcCtD
Rabeprazole—Vomiting—Epirubicin—testicular cancer	6.8e-05	0.000217	CcSEcCtD
Rabeprazole—Nausea—Methotrexate—testicular cancer	6.79e-05	0.000216	CcSEcCtD
Rabeprazole—Diarrhoea—Doxorubicin—testicular cancer	6.77e-05	0.000216	CcSEcCtD
Rabeprazole—Rash—Epirubicin—testicular cancer	6.75e-05	0.000215	CcSEcCtD
Rabeprazole—Dermatitis—Epirubicin—testicular cancer	6.74e-05	0.000215	CcSEcCtD
Rabeprazole—Headache—Epirubicin—testicular cancer	6.7e-05	0.000214	CcSEcCtD
Rabeprazole—Dizziness—Doxorubicin—testicular cancer	6.55e-05	0.000209	CcSEcCtD
Rabeprazole—Nausea—Epirubicin—testicular cancer	6.36e-05	0.000202	CcSEcCtD
Rabeprazole—Vomiting—Doxorubicin—testicular cancer	6.29e-05	0.000201	CcSEcCtD
Rabeprazole—Rash—Doxorubicin—testicular cancer	6.24e-05	0.000199	CcSEcCtD
Rabeprazole—Dermatitis—Doxorubicin—testicular cancer	6.24e-05	0.000199	CcSEcCtD
Rabeprazole—Headache—Doxorubicin—testicular cancer	6.2e-05	0.000198	CcSEcCtD
Rabeprazole—Nausea—Doxorubicin—testicular cancer	5.88e-05	0.000187	CcSEcCtD
